The Food and Drug Administration (FDA) is eyeing to recommend that 12 to 15-year-olds be allowed to receive COVID-19 vaccine from American firm Pfizer-BioNtech.
"Within the week, we will be issuing an amendment to the emergency use authorization of Pfizer and we will be able to use it in children 12 to 15 years old," FDA Director-General Eric Domingo announced during a meeting with President Rodrigo Duterte on Wednesday night.
He added that the US FDA already approved this amendment and has started using vaccines for the age group.
The Philippines earlier received an initial 193,050 doses of Pfizer-BioNtech’s COVID-19 vaccine, courtesy of the COVAX Facility, an initiative by the World Health Organization, the Coalition for Epidemic Preparedness Innovations, and GAVI.
Pfizer was among the first vaccine that was granted an emergency use authorization by the FDA.
Malacañang previously announced that Duterte ordered the vaccination of the A5 priority group or the indigent population using the donated Pfizer jabs by the COVAX Facility.
This, after a huge crowd flocked in a mall in Parañaque earlier this week, a scenario feared to be a possible superspreader event due to the general public’s vaccine preference.
